Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $757.6800 (1.78%) ($740.8400 - $757.6800) on Fri. Feb. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.71% (three month average) | RSI | 61 | Latest Price | $757.6800(1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(46%) XLV(42%) DIA(31%) VYM(29%) SPLV(27%) | Factors Impacting REGN price | REGN will decline at least -0.855% in a week (0% probabilities). VIXM(-11%) VXX(-8%) VCSH(-3%) TBT(-3%) ARKK(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.855% (StdDev 1.71%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $760.32(-0.35%) | 10 Day Moving Average | $759.25(-0.21%) | 20 Day Moving Average | $745.54(1.63%) | To recent high | -3.4% | To recent low | 11.3% | Market Cap | $80.336b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |